Prostigmin in the diagnosis of myasthenia gravis

[1] Aeschlimann JA, 1931, J PHARMACOL EXP THER, V43, P413

[2] Bayley L, 1935, LANCET, V1, P643

[3] BROWN DD, 1935, LANCET, V1, P767

[4] CARMICHAEL EA, 1934, LANCET, V1, P941

[5] CUNN JA, 1908, REV NEUROL PSYCHIAT, V6, P150

[6] Edmunds CW, 1908, AM J PHYSIOL, V23, P28

[7] Hamill P, 1935, LANCET, V1, P575

[8] HAMILL P, 1935, J PHYSL, V84, pP36

[9] Langley JN, 1915, J PHYSIOL-LONDON, V49, P410

[10] Lapicque L, 1912, CR SOC BIOL, V72, P283

[1] Aeschlimann JA, 1931, J PHARMACOL EXP THER, V43, P413

[2] Bayley L, 1935, LANCET, V1, P643

[3] BROWN DD, 1935, LANCET, V1, P767

[4] CARMICHAEL EA, 1934, LANCET, V1, P941

[5] CUNN JA, 1908, REV NEUROL PSYCHIAT, V6, P150

[6] Edmunds CW, 1908, AM J PHYSIOL, V23, P28

[7] Hamill P, 1935, LANCET, V1, P575

[8] HAMILL P, 1935, J PHYSL, V84, pP36

[9] Langley JN, 1915, J PHYSIOL-LONDON, V49, P410

[10] Lapicque L, 1912, CR SOC BIOL, V72, P283